Table 1. Patient demographics.
Characteristic | n | Percent (%) |
---|---|---|
Sex | ||
Male | 52 | 44.8 |
Female | 64 | 55.2 |
Primary tumor type | ||
HCC | 37 | 31.9 |
Colorectal | 30 | 25.8 |
Breast | 18 | 15.6 |
Pancreatic/bile duct | 17 | 14.7 |
Neuroendocrine | 8 | 6.8 |
Other | 6 | 5.2 |
SIRT | ||
Whole liver | 29 | 25 |
Unilobar | 79 | 68 |
Repeat same lobe | 8 | 7 |
Lesion number | ||
1 | 16 | 13.8 |
2 | 10 | 8.6 |
3+ | 90 | 77.6 |
Child-Pugh class | ||
A | 93 | 80.2 |
B | 23 | 19.8 |
ECOG performance status | ||
0-1 | 108 | 93.1 |
2+ | 8 | 6.9 |
Extrahepatic disease | ||
Yes | 23 | 19.8 |
No | 93 | 80.2 |
Number of previous lines of chemotherapy | ||
0 | 73 | 62.9 |
1 | 17 | 14.7 |
2 | 11 | 9.5 |
3+ | 15 | 12.9 |
% liver tumor burden | ||
>25 (median) | 53 | 45.7 |
≤25 (median) | 63 | 54.3 |
HCC, hepatocellular carcinoma; SIRT, selective internal radiation therapy; ECOG, Eastern Cooperative Oncology Group.